Morepen Labs Declares Q2 & H1 FY27 Financial Results

Morepen Laboratories Ltd. announced its un-audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results, based on the recommendation of the Audit Committee, in compliance with SEBI Listing Regulations. The results were reviewed by S.P. Babuta and Associates, Chartered Accountants. The filing includes the limited review reports and details of the group entities, including five subsidiaries whose interim financial results contributed significantly to the consolidated figures.